Dokter Adenokarsinoma di Luar Negeri — Halaman 3

Direktur rawat inap onkologi di Ichilov, salah satu rumah sakit terkemuka di Israel, dan terlibat dalam uji klinis mutakhir sejak 2005.

• Lebih dari 20 tahun pengalaman klinis di bidang onkologi dan penyakit dalam
• Melakukan penelitian primer dan sekunder dalam studi onkologi fase I, II, dan III
• Memiliki izin praktik medis di Israel sejak Januari 2000
• Menjalani pelatihan onkologi melalui magang khusus di Tel Aviv Medical Center

Univ. Prof. Dr. Wolfgang Köstler spesialis dalam kanker payudara dan ginekologi, dengan keahlian lebih dari dua dekade dalam terapi target dan pengobatan personal.

• Profesor Madya di Universitas Kedokteran Wina
• Wakil Kepala Divisi Klinis Onkologi
• Berfokus pada pengembangan biomarker dan biologi tumor
• Konsultan senior di Wiener Privatklinik

Prof. Schoppmann adalah pelopor dalam bedah onkologi invasif minimal, dengan spesialisasi pada kanker esofagus dan lambung di Wiener Privatklinik.

• Memiliki pengalaman lebih dari 20 tahun dalam bedah viseral dan onkologi
• Kepala Unit Bedah Saluran Cerna Atas di Medical University of Vienna
• Pakar dalam teknik robotik untuk kasus kanker yang kompleks
• Mempublikasikan banyak karya tentang biomarker kanker dan mekanisme molekuler

Spesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal, Dr. Ozatli menghadirkan pendekatan terfokus pada pengobatan adenokarsinoma di Rumah Sakit Universitas Istinye Liv.

• Associate Professor sejak 2016
• Pengalaman di berbagai departemen onkologi di Turki
• Pendidikan dari Fakultas Kedokteran Universitas Selcuk

Spesialis dalam viroterapi – salah satu bidang imunologi terbaru. Dr. Jaunalksne membawa 30+ tahun pengalaman ke Pallas Clinic.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga
• Magang di Kedokteran Internal

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.

Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).

Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.

Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.

Dr. Muzaffer Al membawa lebih dari 20 tahun pengalaman bedah, dengan pelatihan khusus dalam bedah kanker laparoskopi dan onkologi.

• Tersertifikasi dewan dengan pelatihan tingkat lanjut dari institusi terkemuka di Turki
• Spesialisasi dalam prosedur antirefluks laparoskopi dan bariatrik
• Fokus pada teknik bedah invasif minimal untuk kanker

Ahli dalam bedah toraks robotik dan invasif minimal – Dr. Dobritoiu menggunakan sayatan kecil untuk pemulihan yang lebih cepat di Ponderas Academic Hospital.

• Spesialisasi dalam bedah toraks robotik menggunakan da Vinci Xi
• Melakukan bedah torakoskopik berbantuan video (VATS) dengan teknik uniportal
• Melakukan reseksi paru dan mediastinum yang kompleks dengan drainase minimal
• Ahli dalam prosedur mediastinoskopi dan bronkoskopi

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Kinas berspesialisasi dalam bedah kanker kompleks, termasuk prosedur pankreas dan saluran empedu, di Rumah Sakit Büyük Anadolu.

• Ahli dalam bedah onkologi dengan fokus pada kanker gastrointestinal
• Melakukan bedah bariatrik dan metabolik tingkat lanjut
• Terampil dalam operasi kanker payudara dan tiroid